Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)

NCT00885872 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipidemia
Atherosclerosis

Interventions

DRUG: Rosuvastatin (Crestor)

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]